{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:12:09Z","timestamp":1791839529541,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":2248,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006026","name":"United States Pharmacopeial Convention","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutrition"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.3945\/jn.115.227280","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T13:25:42Z","timestamp":1478784342000},"page":"2643S-2651S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Importance of Quality Specifications in Safety Assessments of Amino Acids: The Cases of L-Tryptophan and L-Citrulline"],"prefix":"10.1016","volume":"146","author":[{"given":"Hellen A","family":"Oketch-Rabah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill J","family":"Gurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel I","family":"Giancaspro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3945\/jn.115.227280_bib1","unstructured":"Council for Responsible Nutrition. The dietary supplement consumer. The CRN Consumer Survey on Dietary Supplements [cited 2015 Nov 3]. Available from:. http:\/\/www.crnusa.org\/CRNconsumersurvey\/2014\/."},{"key":"10.3945\/jn.115.227280_bib2","series-title":"Herbal dietary supplement sales in US increase 6.8% in 2014","first-page":"52","author":"Smith","year":"2015"},{"key":"10.3945\/jn.115.227280_bib3","first-page":"173","article-title":"Incentivizing safety in the dietary supplement industry","volume":"31","author":"Dagerman","year":"2012","journal-title":"Rev Litig"},{"key":"10.3945\/jn.115.227280_bib4","first-page":"514","article-title":"Current issues regarding complementary and alternative medicine (CAM) in the United States. Part 2: regulatory and safety concerns and proposed governmental policy changes with respect to dietary supplements","volume":"35","author":"Ventola","year":"2010","journal-title":"P&T"},{"key":"10.3945\/jn.115.227280_bib5","first-page":"10","volume":"9","year":"2011","journal-title":"EFSA J"},{"key":"10.3945\/jn.115.227280_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/nure.12087","article-title":"Evidence-based evaluation of potential benefits and safety of beta-alanine supplementation for military personnel","volume":"72","author":"Ko","year":"2014","journal-title":"Nutr Rev"},{"issue":"9 Suppl","key":"10.3945\/jn.115.227280_bib7","doi-asserted-by":"crossref","first-page":"2556S","DOI":"10.1093\/jn\/131.9.2556S","article-title":"Assessment of the safety of glutamine and other amino acids","volume":"131","author":"Garlick","year":"2001","journal-title":"J Nutr"},{"key":"10.3945\/jn.115.227280_bib8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.yrtph.2008.01.004","article-title":"Risk assessment for the amino acids taurine, L-glutamine and L-arginine","volume":"50","author":"Shao","year":"2008","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.3945\/jn.115.227280_bib9","series-title":"Dietary Reference Intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids","year":"2005"},{"key":"10.3945\/jn.115.227280_bib10","unstructured":"US FDA. Dietary supplement current Good Manufacturing Practices (CGMPs) and interim final rule (IFR) facts. [cited 2015 Nov 3]. Available from:. http:\/\/www.fda.gov\/Food\/GuidanceRegulation\/CGMP\/ucm110858.htm."},{"key":"10.3945\/jn.115.227280_bib11","unstructured":"US FDA. Dietary supplements\u2014adverse event reporting. [cited 2015 Nov 3]. Available from:. http:\/\/www.fda.gov\/Food\/DietarySupplements\/ReportAdverseEvent\/."},{"key":"10.3945\/jn.115.227280_bib12","first-page":"2053","volume":"4","year":"2015"},{"key":"10.3945\/jn.115.227280_bib13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/npp.2010.232","article-title":"Effects of direct- and indirect-acting serotonin receptor agonists on the antinociceptive and discriminative stimulus effects of morphine in rhesus monkeys","volume":"36","author":"Li","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.3945\/jn.115.227280_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1550-2783-2-2-63","article-title":"Dietary supplements and sports performance: amino acids","volume":"2","author":"Williams","year":"2005","journal-title":"J Int Soc Sports Nutr"},{"key":"10.3945\/jn.115.227280_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2007-1025027","article-title":"Effect of L-tryptophan supplementation on exercise performance","volume":"9","author":"Segura","year":"1988","journal-title":"Int J Sports Med"},{"key":"10.3945\/jn.115.227280_bib16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1055\/s-2007-1021302","article-title":"L-tryptophan supplementation does not improve running performance","volume":"13","author":"Stensrud","year":"1992","journal-title":"Int J Sports Med"},{"key":"10.3945\/jn.115.227280_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1515\/JPEM.2009.22.9.769","article-title":"Hormonal and metabolic effects of nutrition in athletes","volume":"22","author":"Zadik","year":"2009","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.3945\/jn.115.227280_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jad.2013.05.042","article-title":"Complementary and alternative therapies as add-on to pharmacotherapy for mood and anxiety disorders: a systematic review","volume":"150","author":"Ravindran","year":"2013","journal-title":"J Affect Disord"},{"issue":"Suppl","key":"10.3945\/jn.115.227280_bib19","doi-asserted-by":"crossref","first-page":"2245S","DOI":"10.3945\/jn.112.160846","article-title":"Summary of workshop discussions on establishing upper limits for amino acids with specific attention to available data for the essential amino acids leucine and tryptophan","volume":"142","author":"Kimura","year":"2012","journal-title":"J Nutr"},{"issue":"Suppl","key":"10.3945\/jn.115.227280_bib20","doi-asserted-by":"crossref","first-page":"2231S","DOI":"10.3945\/jn.112.159061","article-title":"Lessons learned regarding symptoms of tryptophan deficiency and excess from animal requirement studies","volume":"142","author":"Moehn","year":"2012","journal-title":"J Nutr"},{"key":"10.3945\/jn.115.227280_bib21","doi-asserted-by":"crossref","first-page":"1996S","DOI":"10.1093\/jn\/138.10.1996S","article-title":"An approach to defining the upper safe limits of amino acid intake","volume":"138","author":"Pencharz","year":"2008","journal-title":"J Nutr"},{"key":"10.3945\/jn.115.227280_bib22","first-page":"587","article-title":"Update: Eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan\u2014United States, through August 24, 1990","volume":"39","year":"1990","journal-title":"Morbidity and Mortality Weekly Report (MMWR)"},{"key":"10.3945\/jn.115.227280_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00011-005-1380-7","article-title":"A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation","volume":"54","author":"Smith","year":"2005","journal-title":"Inflamm Res"},{"key":"10.3945\/jn.115.227280_bib24","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1126\/science.2270484","article-title":"Characterization of \u201cpeak E,\u201d a novel amino acid associated with eosinophilia-myalgia syndrome","volume":"250","author":"Mayeno","year":"1990","journal-title":"Science"},{"key":"10.3945\/jn.115.227280_bib25","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1172\/JCI114902","article-title":"L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat","volume":"86","author":"Crofford","year":"1990","journal-title":"J Clin Invest"},{"key":"10.3945\/jn.115.227280_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199008093230601","article-title":"An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use","volume":"323","author":"Belongia","year":"1990","journal-title":"N Engl J Med"},{"key":"10.3945\/jn.115.227280_bib27","first-page":"2261","article-title":"An eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophan","volume":"21","author":"Michelson","year":"1994","journal-title":"J Rheumatol"},{"key":"10.3945\/jn.115.227280_bib28","series-title":"US Pharmacopeia. Tryptophan monograph","year":"2015"},{"key":"10.3945\/jn.115.227280_bib29","unstructured":"US Pharmacopeia. The United States Pharmacopeia and the National Formulary (USP-NF): development process [cited 2015 Nov 3]. Available from:. http:\/\/www.usp.org\/USPNF\/devProcess\/."},{"key":"10.3945\/jn.115.227280_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.taap.2009.12.005","article-title":"Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment","volume":"243","author":"Jordan","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.3945\/jn.115.227280_bib31","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.jand.2014.01.016","article-title":"Concomitant dietary supplement and prescription medication use is prevalent among US adults with doctor-informed medical conditions","volume":"114","author":"Farina","year":"2014","journal-title":"J Acad Nutr Diet"},{"key":"10.3945\/jn.115.227280_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00175180","article-title":"Evaluation of L-tryptophan for treatment of insomnia: a review","volume":"89","author":"Schneider-Helmert","year":"1986","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3945\/jn.115.227280_bib33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0196-0644(96)70116-6","article-title":"Serotonin syndrome","volume":"28","author":"Martin","year":"1996","journal-title":"Ann Emerg Med"},{"key":"10.3945\/jn.115.227280_bib34","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.genhosppsych.2011.08.014","article-title":"Mania following addition of hydroxytryptophan to monoamine oxidase inhibitor","volume":"34","author":"Pardo","year":"2012","journal-title":"Gen Hosp Psychiatry"},{"key":"10.3945\/jn.115.227280_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2165\/00002018-199513020-00004","article-title":"The serotonin syndrome. Implicated drugs, pathophysiology and management","volume":"13","author":"Sporer","year":"1995","journal-title":"Drug Saf"},{"key":"10.3945\/jn.115.227280_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1248\/bpb1978.13.231","article-title":"Effects of L-tryptophan on the effects of antitussives","volume":"13","author":"Kamei","year":"1990","journal-title":"J Pharmacobiodyn"},{"key":"10.3945\/jn.115.227280_bib37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00431-004-1444-7","article-title":"5-Hydroxytryptophan treatment of sleep terrors in children","volume":"163","author":"Bruni","year":"2004","journal-title":"Eur J Pediatr"},{"key":"10.3945\/jn.115.227280_bib38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/070674378002500507","article-title":"A placebo controlled evaluation of L-tryptophan in depression in the elderly","volume":"25","author":"Cooper","year":"1980","journal-title":"Can J Psychiatry"},{"key":"10.3945\/jn.115.227280_bib39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2125.1986.tb02950.x","article-title":"The disposition of intravenous L-tryptophan in healthy subjects and in patients with liver disease","volume":"22","author":"R\u00f6ssle","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.3945\/jn.115.227280_bib40","first-page":"68","article-title":"Role of tryptophan in the pathogenesis of hepatic encephalopathy","volume":"58","author":"Saleem","year":"2008","journal-title":"J Pak Med Assoc"},{"key":"10.3945\/jn.115.227280_bib41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-1-4615-0135-0_37","article-title":"The influence of L-tryptophan peroral load on glomerular filtration rate in chronic glomerulonephritis and chronic renal failure","volume":"527","author":"Martinsons","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.3945\/jn.115.227280_bib42","unstructured":"Natural Medicines Comprehensive Database. L-Citrulline monograph. 2013. [cited 2015 Nov 3]. Available from:. http:\/\/naturaldatabase.therapeuticresearch.com\/nd\/Search.aspx?pt=100&id=1245&ds."},{"key":"10.3945\/jn.115.227280_bib43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/ajcn\/85.1.167","article-title":"Interorgan amino acid exchange in humans: consequences for arginine and citrulline metabolism","volume":"85","author":"van de Poll","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/jn.115.227280_bib44","unstructured":"National Urea Cycle Disorders Foundation. Citrulline alert. 2014 [cited 2015 Nov 3]. Available from:. http:\/\/www.nucdf.org\/."},{"key":"10.3945\/jn.115.227280_bib45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejphar.2011.05.068","article-title":"Citrulline malate supplementation increases muscle efficiency in rat skeletal muscle","volume":"667","author":"Giannesini","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.3945\/jn.115.227280_bib46","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/pmic.201200262","article-title":"Citrulline enhances myofibrillar constituents expression of skeletal muscle and induces a switch in muscle energy metabolism in malnourished aged rats","volume":"13","author":"Faure","year":"2013","journal-title":"Proteomics"},{"key":"10.3945\/jn.115.227280_bib47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1527-3466.2006.00275.x","article-title":"Therapeutic use of citrulline in cardiovascular disease","volume":"24","author":"Romero","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"issue":"Suppl","key":"10.3945\/jn.115.227280_bib48","doi-asserted-by":"crossref","first-page":"1693S","DOI":"10.1093\/jn\/137.6.1693S","article-title":"Adverse gastrointestinal effects of arginine and related amino acids","volume":"137","author":"Grimble","year":"2007","journal-title":"J Nutr"},{"key":"10.3945\/jn.115.227280_bib49","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1017\/S0007114507841110","article-title":"Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose Pharmacokinetic Study","volume":"99","author":"Moinard","year":"2008","journal-title":"Br J Nutr"},{"key":"10.3945\/jn.115.227280_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijcard.2010.10.004","article-title":"Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men","volume":"155","author":"Ochiai","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.3945\/jn.115.227280_bib51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ajh.2010.142","article-title":"Effects of watermelon supplementation on aortic blood pressure and wave reflection in individuals with prehypertension: a pilot study","volume":"24","author":"Figueroa","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.3945\/jn.115.227280_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/ajh.2009.195","article-title":"Oral L-citrulline supplementation attenuates blood pressure response to cold pressor test in young men","volume":"23","author":"Figueroa","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.3945\/jn.115.227280_bib53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtcvs.2006.02.012","article-title":"Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline","volume":"132","author":"Smith","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.3945\/jn.115.227280_bib54","unstructured":"US Food and Drug Administration. FDA lab testing finds N-acetyl-leucine in samples of recalled Medisca product labeled as L-citrulline. 2014 [cited 2015 Nov 3]. Available from:. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm385964.htm."},{"key":"#cr-split#-10.3945\/jn.115.227280_bib55.1","unstructured":"US Pharmacopeia. Citrulline monograph. Pharmacopeial Forum 2015;41"},{"key":"#cr-split#-10.3945\/jn.115.227280_bib55.2","unstructured":"(6) [cited 2015 Nov 3]. Available from:. http:\/\/www.usppf.com\/pf\/pub\/index.html."},{"key":"10.3945\/jn.115.227280_bib56","series-title":"USP. Chapter <233> Elemental impurities\u2014procedures In: USP 39. 2nd suppl","first-page":"7597","year":"2015"},{"key":"10.3945\/jn.115.227280_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2125.2007.02990.x","article-title":"Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism","volume":"65","author":"Schwedhelm","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.3945\/jn.115.227280_bib58","doi-asserted-by":"crossref","unstructured":"Aquilani R, D\u2019Antona G, Baiardi P, Gambino A, Iadarola P, Viglio S, Pasini E, Verri M, Barbieri A, Boschi F. Essential amino acids and exercise tolerance in elderly muscle-depleted subjects with chronic diseases: a rehabilitation without rehabilitation? Biomed Res Int 2014;2014:341603. 8 p. [cited 2015 Nov 3]. Available from:. https:\/\/www.hindawi.com\/journals\/bmri\/2014\/341603\/.","DOI":"10.1155\/2014\/341603"},{"key":"10.3945\/jn.115.227280_bib59","unstructured":"National Cancer Institute. Automated Self-Administered 24-hour (ASA24) Dietary Recall System [Internet]. 2016 [cited 2016 Mar 29]. Available from:. http:\/\/www.cdc.gov\/nchs\/hus\/special.htm."},{"key":"10.3945\/jn.115.227280_bib60","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1124\/dmd.113.055236","article-title":"Herb-drug interactions: challenges and opportunities for improved predictions","volume":"42","author":"Brantley","year":"2014","journal-title":"Drug Metab Dispos"}],"container-title":["The Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316623008192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316623008192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/jn\/article-pdf\/146\/12\/2643S\/23968945\/jn227280.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T16:25:03Z","timestamp":1735662303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022316623008192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0022316623008192"],"URL":"https:\/\/doi.org\/10.3945\/jn.115.227280","relation":{},"ISSN":["0022-3166"],"issn-type":[{"value":"0022-3166","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Importance of Quality Specifications in Safety Assessments of Amino Acids: The Cases of L-Tryptophan and L-Citrulline","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/jn.115.227280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Nutrition. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}